The outbreak of SARS‐CoV‐2 Omicron lineages, immune escape, and vaccine effectivity-Reference-Cited by-同舟云学术

The outbreak of SARS‐CoV‐2 Omicron lineages, immune escape, and vaccine effectivity

Published:2022-09-21 Issue:1 Volume:95 Page:
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:Journal of Medical Virology

Author:

Zhou Yongbing¹,Zhi Huilin²,Teng Yong¹^ORCID

Affiliation:

1. Department of Clinical Laboratory, Hangzhou Third People's Hospital, Affiliated Hangzhou Dermatology Hospital Zhejiang University School of Medicine Hangzhou China

2. Department of Dermatology, Hangzhou Third People's Hospital, Affiliated Hangzhou Dermatology Hospital Zhejiang University School of Medicine Hangzhou China

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.28138

Reference87 articles.

1. Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020

2. South Africa responds to new SARS-CoV-2 variant

3. Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil

4. The emergence and epidemic characteristics of the highly mutated SARS‐CoV‐2 Omicron variant

5. Hepatic complications of COVID‐19 and its treatment

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MVA-based vaccine candidates expressing SARS-CoV-2 prefusion-stabilized spike proteins of the Wuhan, Beta or Omicron BA.1 variants protect transgenic K18-hACE2 mice against Omicron infection and elicit robust and broad specific humoral and cellular immune responses;Frontiers in Immunology;2024-08-29

2. Retrospective Analysis of Omicron in Minas Gerais, Brazil: Emergence, Dissemination, and Diversification;Microorganisms;2024-08-23

3. Efficacy, immunogenicity and safety of CoronaVac® in children and adolescents aged 6 months to 17 years: a multicenter, randomized, double-blind, placebo-controlled phase III clinical trial;Nature Communications;2024-08-06

4. Why is the Omicron main protease of SARS-CoV-2 less stable than its wild-type counterpart? A crystallographic, biophysical, and theoretical study;hLife;2024-08

5. Humoral and Innate Immunological Profile of Paediatric Recipients of Pfizer-BioNTech BNT162b2 mRNA Vaccine;Microorganisms;2024-07-09